Clinical trial
A Multicenter Randomized Trial Evaluating the Efficacy of Sarpogrelate on Ischemic Heart Disease After Drug-eluting Stent Implantation in Patients With Diabetes Mellitus or Renal Impairment
NCT02294643 is registered in ClinicalTrials.gov with Seoul National University Bundang Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter Randomized Trial Evaluating the Efficacy of Sarpogrelate on Ischemic Heart Disease After Drug-eluting Stent Implantation in Patients With Diabetes Mellitus or Renal Impairment
- Lead sponsor
- Seoul National University Bundang Hospital
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- April 30, 2009
- Completion date
- March 31, 2014
- Enrollment
- 220 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.